Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A new compound and its application

A technology for compounds and compositions, applied in the fields of drug combination, digestive system, biochemical equipment and methods, etc., can solve problems such as hidden safety hazards, incompatibility, accumulation of toxicity, etc.

Active Publication Date: 2020-10-30
KYLONOVA (XIAMEN) BIOPHARMA CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, anionic liposomes, pH-sensitive liposomes, immunoliposomes, fusogenic liposomes, and cationic lipids, etc., although some progress has been made, liposomes themselves are prone to inflammatory reactions , a variety of antihistamines and hormones such as cilitizine and dexamethasone must be used before administration to reduce possible acute inflammatory reactions, so it is not suitable for all therapeutic areas in actual clinical applications, especially as For diseases such as chronic hepatitis B with a long treatment cycle, the accumulated toxicity that may occur after long-term use is a potential safety hazard

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A new compound and its application
  • A new compound and its application
  • A new compound and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0146] Embodiment 1, the synthesis of GBL-0401

[0147] 1. Synthesis of Kys-01

[0148] 1.1. Compounds with 5'YICd-01 structure: Synthesis of 5'YICd-01-PFP

[0149] 1.1.1. Synthesis of 5'YICd-01-c1

[0150]

[0151] Measure 5.0 g (81.9 mmol) of 2-hydroxyethylamine, add 50 mL of dimethyl sulfoxide, 5 mL of sodium hydroxide solution (concentration 1 g / mL), add 12 mL (81.9 mmol) of tert-butyl acrylate dropwise for 1 hour, and After reacting for 24 hours, 100 mL of petroleum ether was added, washed twice with saturated brine, and the organic layer was dried. After passing through the column, 7.5 g of a colorless oily substance was obtained.

[0152] 1.1.2. Synthesis of 5'YICd-01-c2

[0153]

[0154] Weigh 7.5g (39.7mmol) of 5'YICd-01-c1, add 50mL of DCM, 23mL of sodium carbonate solution (25%), add 7.7g (45.0mmol) of benzyl chloroformate dropwise at room temperature, react overnight at room temperature, wash with saturated saline Twice, dried over anhydrous sodium sulfate...

Embodiment 2

[0212] Embodiment two, the synthesis of GBL-0402

[0213] 1. Synthesis of Kys-02

[0214] 1.1. Compounds with 5'YICc-01 structure: Synthesis of 5'YICc-01-PFP

[0215] 1.1.1. Synthesis of 5’YICc-01-c1

[0216]

[0217] Take 7.0g (40.0mmol) of SANC-c8 and 9.2g (34.4mmol) of 5’YICd-01-c3, add 25mL of DMF to dissolve, add 9.0g of TBTU, cool down to 10°C, add 2ml of DIEA, and react overnight at room temperature. Add 30 mL of water and 50 mL of dichloromethane, and wash the organic layer three times with saturated brine. The organic layer was dried and evaporated to dryness under reduced pressure. After passing through a column chromatography (eluent: dichloromethane: methanol = 1%-10%), 10.0 g of a yellow viscous solid was obtained.

[0218] 1.1.2. Synthesis of 5'YICc-01-c2

[0219]

[0220] Take 10.0g of 5'YICc-01-c1, add 15ml of concentrated hydrochloric acid, and react overnight at room temperature. Evaporate to dryness under reduced pressure to obtain 7.3g.

[0221...

Embodiment 3

[0251] Embodiment three, the synthesis of GBL-0403

[0252] 1. Synthesis of Kys-03

[0253]1.1. Compounds with 5’ERCd-01 structure: Synthesis of 5’ERCd-01-PFP

[0254] 1.1.1. Synthesis of 5’ERCd-01-c1

[0255]

[0256] Measure 5.0g (54.9mmol) of 2-amino-1,3-propanediol, add 50mL of DMSO, 5mL of sodium hydroxide solution (concentration: 1g / mL), cool down to 0°C, add dropwise 20mL (137.8mol) of tert-butyl acrylate2 After the addition was completed in 1 hour, react at room temperature for 48 hours, add 100 mL of petroleum ether, wash with saturated brine twice, and dry the organic layer. After passing through a chromatography column (eluent: ethyl acetate: petroleum ether = 25%-75%), add 0.05% triethylamine to the column to obtain 6.2 g of a colorless oil.

[0257] 1.1.2. Synthesis of 5’ERCd-01-c2

[0258]

[0259] Weigh 6.2g (17.9mmol) of 5'ERCd-01-c1, add 50mL of dichloromethane, 23mL of sodium carbonate solution (25%), add 8.2mL of benzyl chloroformate (57.4mmol) dro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a novel compound. The structure of the compound contains an interfering nucleic acid, a transition point and a modified chain at its end. Said terminal modification chain can introduce two or three N-acetyl galactosamines at the 3' end of the antisense strand of the interfering nucleic acid, and two or one N-acetylgalactosamines can be introduced at the 5' end of the sense strand correspondingly. N-acetylgalactosamine, the total number of N-acetylgalactosamine introduced is four. In vivo and in vitro pharmacodynamic experiments have proved that this new compound can continuously and efficiently inhibit HBV gene expression.

Description

technical field [0001] The present invention relates to a novel compound. The structure of the compound contains an interfering nucleic acid, a transition point and a modified chain at its end. By modifying the end of the strand, two to three N-acetylgalactosamines can be introduced at the 3' end of the antisense strand of this siRNA, and two to one N-acetylgalactose can be introduced at the 5' end of the sense strand amines, the total number of N-acetylgalactosamines introduced was four. The drug efficacy experiments on HepG 2 cells and transgenic mice prove that this new compound can continuously inhibit the expression of HBsAg, HBeAg and HBV DNA of HBV. Background technique [0002] RNAi [0003] RNAi (RNA interference) was discovered in 1998 by Andrew Z. Fire et al. when conducting antisense RNA inhibition experiments in Caenorhabditis elegans, and this process was called RNAi. This discovery was rated as one of the top ten scientific advances in 2001 by the "Science...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/113A61K31/713A61P1/16
CPCC12N15/113A61K31/713A61P1/16C12N2310/14C12N2310/31C12N2310/351C12N15/1131A61K47/549A61K47/545A61K47/55A61P31/20C12N2310/11
Inventor 卢雪琴穆卓王圣军杜艳春
Owner KYLONOVA (XIAMEN) BIOPHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com